Dec 01, 2022 / 09:20PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Okay. Well, my last session, my last fireside for our 2022 Healthcare Conference. Pleasure to have Pfizer management join us. I'll turn it over to our old friend, Chris, from the buy side to kick things off and introduce the management.
Christopher J. Stevo - Pfizer Inc. - Senior VP & Chief IR Officer
Thanks so much, Umer. So I'm very pleased to introduce you to my colleagues, Angela Hwang. She's our Chief Commercial Officer and President of the Global Biopharmaceutical business; Kevin Sullivan, the President of our Specialty Care business. And finally, Navin Katyal, who's the Head of our mRNA business, especially focusing on mRNA vaccines. So thank you for your time and for your kind introduction.
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Outstanding. Angela, perhaps it would be great if you could kick things off and
Pfizer Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 02, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers